Literature DB >> 17638822

Ocular surface toxicity associated with topical interferon alpha-2b.

Anthony J Aldave, Anne Nguyen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638822      PMCID: PMC1954794          DOI: 10.1136/bjo.2006.107482

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  21 in total

1.  Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C.

Authors:  Y Rozenman; J Frucht-Pery
Journal:  Cornea       Date:  2000-01       Impact factor: 2.651

2.  Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.

Authors:  Barry A Schechter; Amilia Schrier; Robert S Nagler; Edward F Smith; Gabriel E Velasquez
Journal:  Cornea       Date:  2002-01       Impact factor: 2.651

3.  Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.

Authors:  David J Holcombe; Graham A Lee
Journal:  Am J Ophthalmol       Date:  2006-10       Impact factor: 5.258

4.  Comparison of the prophylactic effects of 2-deoxycytidine and prednisolone for high-dose intravenous cytarabine-induced keratitis.

Authors:  H M Lazarus; M E Hartnett; M D Reed; B F Murphy; J H Lass
Journal:  Am J Ophthalmol       Date:  1987-11-15       Impact factor: 5.258

5.  Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma.

Authors:  Joseph Frucht-Pery; Yaacov Rozenman; Jacob Pe'er
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

6.  Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.

Authors:  Michael D Boehm; Andrew J W Huang
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

7.  Lack of toxicity of a topical recombinant interferon alpha.

Authors:  M Smith; M D Trousdale; N A Rao; J B Robin
Journal:  Cornea       Date:  1989       Impact factor: 2.651

8.  A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.

Authors:  Mario A Di Pascuale; Edgar M Espana; Scheffer C G Tseng
Journal:  Cornea       Date:  2004-01       Impact factor: 2.651

9.  Corneal toxicity with systemic cytarabine.

Authors:  G Hopen; B J Mondino; B L Johnson; P A Chervenick
Journal:  Am J Ophthalmol       Date:  1981-04       Impact factor: 5.258

10.  Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b.

Authors:  Akira Kobayashi; Tsuyoshi Yoshita; Kayo Uchiyama; Yutaka Shirao; Kazuko Kitagawa; Aya Fujisawa; Scheffer C G Tseng
Journal:  Jpn J Ophthalmol       Date:  2002 Mar-Apr       Impact factor: 2.447

View more
  5 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

2.  [Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis].

Authors:  E Torres Suárez; R Pinheiro; N Schrage
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

3.  Ocular surface tumors.

Authors:  Meghana Anika Varde; Jyotirmay Biswas
Journal:  Oman J Ophthalmol       Date:  2009-01

Review 4.  Update on pharmacotherapy for ocular surface squamous neoplasia.

Authors:  Ghada Al Bayyat; Dan Arreaza-Kaufman; Nandini Venkateswaran; Anat Galor; Carol L Karp
Journal:  Eye Vis (Lond)       Date:  2019-08-12

5.  Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia.

Authors:  Reza Ghaffari; Sahar Barijani; Arash Alivand; Golshan Latifi; Hamed Ghassemi; Mehran Zarei-Ghanavati; Ali R Djalilian
Journal:  J Curr Ophthalmol       Date:  2021-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.